GlycoNex has received Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) approval to commence a first-in-human Phase I ...
Idorsia Ltd (SIX: IDIA) and Idorsia Pharmaceuticals Japan today announce that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved PIVLAZ™ (clazosentan sodium) 150 mg, a ...
This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. : Op-ed: PMDA advances regulatory science-based ...
“We are thankful for PMDA’s engagement and for the unanimous support of the world class cardiologists from Japan and the United States attending the meeting,” said BioCardia Chief Executive Dr. Peter ...
Pharmaceuticals and Medical Devices Agency (PMDA) has succeeded in shortening the review period for medical products to the world's top standard through its 1st and 2nd Mid-term Plan Periods (FY 2004 ...
GlycoNex receives Japan’s PMDA approval to initiate first-in-human phase 1 trial of GNX1021 in gastrointestinal cancers: New Taipei City, Taiwan Thursday, April 16, 2026, 16:00 ...
New Delhi: Lupin has received a good manufacturing practice (GMP) certificate from Japan's Pharmaceutical and Medical Devices Agency (PMDA) for its bulk drug manufacturing facility at Mandideep in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results